CLEC-1 Restrains Acute Inflammatory Response and Recruitment of Neutrophils following Tissue Injury
The Journal of Immunology · 2024
DOI: 10.4049/jimmunol.2300479 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Camille Ligeron und 12 weiteren Autor:innen. Beteiligte Einrichtung: OSE Immunotherapeutics, Nantes, France. Hauptthemen laut MEDLINE: Neutrophils, Inflammation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Agence Nationale de la Recherche (ANR), Association Nationale de la Recherche et de la Technologie (ANRT).
Abstract (Originalsprache)
The inflammatory response is a key mechanism for the elimination of injurious agents but must be tightly controlled to prevent additional tissue damage and progression to persistent inflammation. C-type lectin receptors expressed mostly by myeloid cells play a crucial role in the regulation of inflammation by recognizing molecular patterns released by injured tissues. We recently showed that the C-type lectin receptor CLEC-1 is able to recognize necrotic cells. However, its role in the acute inflammatory response following tissue damage had not yet been investigated. We show in this study, in a mouse model of liver injury induced by acetaminophen intoxication, that Clec1a deficiency enhances the acute immune response with increased expression of Il1b, Tnfa, and Cxcl2 and higher infiltration of activated neutrophils into the injured organ. Furthermore, we demonstrate that Clec1a deficiency exacerbates tissue damage via CXCL2-dependent neutrophil infiltration. In contrast, we observed that the lack of CLEC-1 limits CCL2 expression and the accumulation, beyond the peak of injury, of monocyte-derived macrophages. Mechanistically, we found that Clec1a-deficient dendritic cells increase the expression of Il1b, Tnfa, and Cxcl2 in response to necrotic cells, but decrease the expression of Ccl2. Interestingly, treatment with an anti-human CLEC-1 antagonist mAb recapitulates the exacerbation of acute immunopathology observed by genetic loss of Clec1a in a preclinical humanized mouse model. To conclude, our results demonstrate that CLEC-1 is a death receptor limiting the acute inflammatory response following injury and represents a therapeutic target to modulate immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- OSE Immunotherapeutics, Nantes, France.
- Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.
ORCID-Profile: Javier Saenz, Marion Drouin, Kevin Biteau, Emmanuelle Wilhelm, Elise Chiffoleau
Förderung
- Agence Nationale de la Recherche (ANR)
- Association Nationale de la Recherche et de la Technologie (ANRT)
Zitieren
APA
Ligeron, C., Saenz, J., Evrard, B., Drouin, M., Merieau, E., Mary, C., Biteau, K., Wilhelm, E., Batty, C., Gauttier, V., Baccelli, I., Poirier, N., & Chiffoleau, E. (2024). CLEC-1 Restrains Acute Inflammatory Response and Recruitment of Neutrophils following Tissue Injury. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300479
Vancouver
Ligeron C, Saenz J, Evrard B, Drouin M, Merieau E, Mary C, et al. CLEC-1 Restrains Acute Inflammatory Response and Recruitment of Neutrophils following Tissue Injury. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2300479
BibTeX
@article{Ligeron2024,
author = {Ligeron, Camille and Saenz, Javier and Evrard, Berangere and Drouin, Marion and Merieau, Emmanuel and Mary, Caroline and Biteau, Kevin and Wilhelm, Emmanuelle and Batty, Cécile and Gauttier, Vanessa and Baccelli, Irene and Poirier, Nicolas and Chiffoleau, Elise},
title = {CLEC-1 Restrains Acute Inflammatory Response and Recruitment of Neutrophils following Tissue Injury},
journal = {The Journal of Immunology},
year = {2024},
doi = {10.4049/jimmunol.2300479}
}
EUVIMED